ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPONSORED PUBLICATIONS

DROOMS - Whitepaper

14 Must-Haves to Boost the Efficiency of Your Data Room

Stop wasting time with data room software that doesn’t really improve your workflow. more ➔

The Jackson Laboratory

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies. more ➔

ADVERTISEMENT

RightsDirect

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

How Content Access and Manual Process Hinder Mining Efforts more ➔

placeholder

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 21 of 21«‹192021

LATEST NEWS

HQ of Boehringer IngelheimBoehringer Ingelheim

Boehringer Ingelheim in US$570m deal with CDR-Life

Artist's image of the eyeadobe stock photos - MikeCS Images

AAVantgarde secures $141m Series B funding

Novo logoAdobe stock photos - https://european-biotechnology.com/latest-news/roche-moves-obesity-asset-ct-388-into-phase-iii/

Novo and Pfizer in Metsera takeover battle

ADVERTISEMENT

MAGAZINE

1 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

2 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

3 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

4 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

SPONSORED PUBLICATION

1 / 3
Co-founder and CEO T3 Dr. Simon IttigT3 Pharmaceuticals
Basel Area

How T3 scaled faster in Basel’s biotech labs

T3 Pharmaceuticals shows how a biotech can move from first experiments to a major international deal keeping pace - and roots - in the Basel Area. The team built, tested and scaled inside Switzerland … more ➔

2 / 3
Image 960x540
Gene Therapy

Innovative Approaches to Gene Therapy

Watch this expert-led session to explore the latest trends and insights in gene therapy, including how to model immunosuppressive regimens, key study-design considerations, and the importance of age … more ➔

3 / 3
25Q3_Digitizing-Mfg-for-Annex-11-and-MHRA-Rediness_Banners_960x540
Whitepaper Digital Manufacturing

Tackling 5 Key Challenges in Annex 11 and MHRA Readiness

Download the guide to explore how forward-thinking organisations are leveraging digital transformation in manufacturing to overcome regulatory challenges, enhance compliance, and gain operational … more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top